AU2002325305A1 - Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression - Google Patents

Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression

Info

Publication number: AU2002325305A1
Authority: AU; Australia
Prior art keywords: gene expression; targeted inhibition; novel; oligoribonucleotide derivatives; derivatives
Prior art date: 2001-07-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002325305A

Other versions

AU2002325305B2 (en

Inventor

Niki Gunkel

Jochen Huber

Sandra Neumann

Eugen Uhlmann

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis Deutschland GmbH

Original Assignee

Sanofi Aventis Deutschland GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-12

Filing date

2002-07-05

Publication date

2003-05-22

2001-07-12 Priority claimed from DE10133915A external-priority patent/DE10133915A1/en

2002-07-05 Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH

2003-05-22 Publication of AU2002325305A1 publication Critical patent/AU2002325305A1/en

2005-12-15 Assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH reassignment SANOFI-AVENTIS DEUTSCHLAND GMBH Request for Assignment Assignors: AVENTIS PHARMA DEUTSCHLAND GMBH

2007-05-17 Application granted granted Critical

2007-05-17 Publication of AU2002325305B2 publication Critical patent/AU2002325305B2/en

2022-07-05 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10133915.1		2001-07-12
DE10133915A DE10133915A1 (en)	2001-07-12	2001-07-12	New oligoribonucleotide derivatives for targeted inhibition of gene expression
PCT/EP2002/007483 WO2003008595A2 (en)	2001-07-12	2002-07-05	Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression

Publications (2)

Publication Number	Publication Date
AU2002325305A1 true AU2002325305A1 (en)	2003-05-22
AU2002325305B2 AU2002325305B2 (en)	2007-05-17

Family

ID=7691545

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002325305A Ceased AU2002325305B2 (en)	2001-07-12	2002-07-05	Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression

Country Status (14)

Country	Link
US (2)	US20030105052A1 (en)
EP (1)	EP1414961B1 (en)
JP (1)	JP4690649B2 (en)
AT (1)	ATE371734T1 (en)
AU (1)	AU2002325305B2 (en)
CA (1)	CA2453295C (en)
CY (1)	CY1107776T1 (en)
DE (2)	DE10133915A1 (en)
DK (1)	DK1414961T3 (en)
ES (1)	ES2289131T3 (en)
IL (2)	IL159759A0 (en)
MX (1)	MXPA04000178A (en)
PT (1)	PT1414961E (en)
WO (1)	WO2003008595A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1572902B1 (en)	2002-02-01	2014-06-11	Life Technologies Corporation	HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
EP2128248B2 (en)	2002-02-01	2017-01-11	Life Technologies Corporation	Oligonucleotide compositions with enhanced efficiency
US20060009409A1 (en)	2002-02-01	2006-01-12	Woolf Tod M	Double-stranded oligonucleotides
US7803781B2 (en) *	2003-02-28	2010-09-28	Isis Pharmaceuticals, Inc.	Modulation of growth hormone receptor expression and insulin-like growth factor expression
DE10350256A1 (en) *	2003-10-01	2005-06-02	Grünenthal GmbH	PIM-1-specific siRNA compounds
DE102004011687A1 (en) *	2004-03-10	2005-10-13	Grünenthal GmbH	VGLUT-specific dsRNA compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3717436A1 (en) *	1987-05-23	1988-12-08	Hoechst Ag	METHOD FOR PRODUCING DOUBLE-STRANDED DNA
KR930016437A (en)	1992-01-22	1993-08-26	귀틀라인, 슈미트	Oligonucleotide Analogues, Methods for Making and Uses thereof
US5886165A (en) *	1996-09-24	1999-03-23	Hybridon, Inc.	Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments
US6010907A (en) *	1998-05-12	2000-01-04	Kimeragen, Inc.	Eukaryotic use of non-chimeric mutational vectors
US6004804A (en) *	1998-05-12	1999-12-21	Kimeragen, Inc.	Non-chimeric mutational vectors
WO2000004189A1 (en) *	1998-07-14	2000-01-27	Isis Pharmaceuticals, Inc.	Modified oligonucleotides

2001
- 2001-07-12 DE DE10133915A patent/DE10133915A1/en not_active Withdrawn
2002
- 2002-07-05 EP EP02758317A patent/EP1414961B1/en not_active Expired - Lifetime
- 2002-07-05 DE DE50210819T patent/DE50210819D1/en not_active Expired - Lifetime
- 2002-07-05 AU AU2002325305A patent/AU2002325305B2/en not_active Ceased
- 2002-07-05 PT PT02758317T patent/PT1414961E/en unknown
- 2002-07-05 ES ES02758317T patent/ES2289131T3/en not_active Expired - Lifetime
- 2002-07-05 IL IL15975902A patent/IL159759A0/en unknown
- 2002-07-05 AT AT02758317T patent/ATE371734T1/en active
- 2002-07-05 DK DK02758317T patent/DK1414961T3/en active
- 2002-07-05 MX MXPA04000178A patent/MXPA04000178A/en active IP Right Grant
- 2002-07-05 JP JP2003514911A patent/JP4690649B2/en not_active Expired - Fee Related
- 2002-07-05 WO PCT/EP2002/007483 patent/WO2003008595A2/en active IP Right Grant
- 2002-07-05 CA CA2453295A patent/CA2453295C/en not_active Expired - Fee Related
- 2002-07-11 US US10/192,926 patent/US20030105052A1/en not_active Abandoned
2004
- 2004-01-07 IL IL159759A patent/IL159759A/en not_active IP Right Cessation
2005
- 2005-09-22 US US11/233,907 patent/US7635769B2/en not_active Expired - Fee Related
2007
- 2007-10-25 CY CY20071101371T patent/CY1107776T1/en unknown

Similar Documents

Publication	Publication Date	Title
AU2002229701A1 (en)	2003-02-06	Method for inhibiting the expression of a target gene
AU2002345089A1 (en)	2003-05-22	Synthetic double stranded oligonucleotides for targeted inhibition of gene expression
AU2002253836A1 (en)	2002-08-19	Aptamer-mediated regulation of gene expression
AU2002350228A1 (en)	2003-06-10	Antisense modulation of myd88 expression
AU2003287254A1 (en)	2004-05-25	Inhibition of gene expression using rna interfering agents
AU2003222197A1 (en)	2003-09-02	Inhibition of rna function
AU2002325305A1 (en)	2003-05-22	Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression
AU2002219992A1 (en)	2002-06-11	Targeted regulation of gene expression
AU2001259595A1 (en)	2001-11-20	Haplotypes of the crybb1 gene
AU2002317373A1 (en)	2003-02-17	Control of gene expression
AU2001255402A1 (en)	2001-10-30	Haplotypes of the npr1 gene
AU2002366033B2 (en)	2008-11-27	Method of inhibiting gene expression
AU2001290603A1 (en)	2002-03-13	Haplotypes of the or11a1 gene
AU2002230657A1 (en)	2002-06-11	Haplotypes of the sah gene
AU2001255697A1 (en)	2001-11-07	Regulation of gene expression by hspbp1
AU2001296510A1 (en)	2002-04-08	Haplotypes of the admr gene
AU2001257050A1 (en)	2001-10-30	Haplotypes of the zfp36 gene
AU2001273847A1 (en)	2001-10-30	Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene
AU2002239511A1 (en)	2002-06-03	Haplotypes of the gsr gene
AU2002213185A1 (en)	2002-04-29	Haplotypes of the chrm5 gene
AU2001274995A1 (en)	2001-12-11	Haplotypes of the rlbp1 gene
AU2001286644A1 (en)	2002-03-13	Haplotypes of the gng7 gene
AU2001292815A1 (en)	2002-03-26	Haplotypes of the scya8 gene
AU2002227177A1 (en)	2002-04-29	Haplotypes of the scya21 gene
AU2001249650A1 (en)	2001-10-15	Haplotypes of the chrnb3 gene